Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants

NCT01616459 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

953

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Streptococcal

Interventions

BIOLOGICAL: Pneumococcal conjugate vaccine GSK2830929A
BIOLOGICAL: Pneumococcal conjugate vaccine GSK2830930A
BIOLOGICAL: Synflorix™
BIOLOGICAL: Prevnar 13™
BIOLOGICAL: Infanrix hexa™

Sponsor

GlaxoSmithKline